BL is characterised by the presence of a germinal centre B‐cell phenotype, proliferation fraction approaching 100%, and t(8;14) or variant MYC rearrangement (MYC‐R) as the sole cytogenetic abnormality [1, 2, 3]. The gene discussed is MYC; the disease is Burkitt lymphoma.